The expression of GFPT2, an isoenzyme of GFPT1, is specifically induced in KRAS/LKB1 combined mutant lung cancer cells, and promotes tumorigenicity by enhancing glucose influx into HBP. The gene discussed is STK11; the disease is lung carcinoma.